CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 420 enrolled
Drug / intervention
MASLIHAT +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04853394
NCT04853394N/ACompleted

MASLIHAT Intervention for Tajik Male Migrants Who Inject Drugs

University of Illinois at Chicago·interventional·Posted Apr 21, 2021·Updated Dec 6, 2024

In Brief

A clinical study evaluating MASLIHAT and TANSIHAT for HIV Infections and 3 related conditions. Completed, enrolled 420 participants across 1 site.

Detailed Summary

This study will test the efficacy of a peer-education prevention intervention to reduce risky drug, alcohol, and sexual behaviors among male Tajik labor migrants who inject drugs (MWID) while working in Moscow. The peer educator intervention will be compared to a health education control intervention. Each intervention consists of 5 weekly 2-hour small group sessions. Follow-up assessments will be conducted at 3, 6, 9, and 12 months after the intervention. It is hypothesized that, compared to MWID who receive the health education control intervention, those who receive the peer educator intervention will have a greater reduction in the frequency of risk behaviors. Similar effects are expected for network members of intervention participants.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesRussia

Timeline

N/ACompletedFinished
20222023202420252026
First PostedApr 21, 2021
Enrollment StartOct 19, 2021
Primary CompletionMay 4, 2023
Study CompletionMay 28, 2023
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 5.2 years ago

Interventions

MASLIHATbehavioral

peer educator intervention

TANSIHATbehavioral

health education intervention